Related Experiment Videos
Evaluation of cefoxitin prophylaxis for cesarean section.
Summary
Prophylactic cefoxitin significantly reduced infection rates in cesarean section patients. This broad-spectrum antibiotic proved safe and effective for all women undergoing the procedure, minimizing pelvic and wound infections.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Pharmacology
Background:
- Cesarean section is associated with a significant risk of surgical site infections.
- Effective prophylactic antibiotic strategies are crucial to reduce maternal morbidity.
Purpose of the Study:
- To evaluate the efficacy and safety of prophylactic cefoxitin in preventing infections after cesarean section.
- To compare infection rates between cefoxitin and placebo groups.
Main Methods:
- A double-blind, randomized trial involving 101 patients undergoing cesarean section.
- Patients received a three-dose regimen of either cefoxitin or a placebo, with the first dose administered after cord clamping.
- Infection risk factors were analyzed to identify patient subgroups benefiting from prophylaxis.
Main Results:
- The incidence of pelvic or wound infection was significantly lower in the cefoxitin group (4%) compared to the placebo group (29%) (P < 0.003).
- No serious adverse events, including re-operation, re-admission, or life-threatening infections, were reported in either group.
- Cefoxitin demonstrated broad-spectrum aerobic and anaerobic coverage.
Conclusions:
- Cefoxitin is an effective and safe prophylactic agent for all patients undergoing cesarean section.
- Prophylactic cefoxitin significantly decreases the risk of post-cesarean infection.
- The study supports the routine use of cefoxitin for infection prophylaxis in cesarean deliveries.